Daewoong, Presents

Daewoong Presents Enavogliflozin's Phase 3 Pooled Analysis Results at 84th ADA Conference

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Daewoong Pharmaceutical Co., Ltd. Bahrain Iran Iraq Jordan Kuwait Lebanon Oman Palestine Qatar Saudi Arabia Syria United Arab Emirates Yemen South Korea Florida

en | boerse | 67935970 |